JB Chemicals & Pharmaceuticals Ltd. (IN:JBCHEPHARM)
:JBCHEPHARM
Total Valuation
JB Chemicals & Pharmaceuticals Ltd. has a market cap or net worth of ₹312.35B. The enterprise value is ₹311.36B.
Market Cap₹312.35B
Enterprise Value₹311.36B
Share Statistics
JB Chemicals & Pharmaceuticals Ltd. has 160,558,700 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding160,558,700
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
JB Chemicals & Pharmaceuticals Ltd.’s return on equity (ROE) is 0.19 and return on invested capital (ROIC) is 17.34%.
Return on Equity (ROE)0.19
Return on Assets (ROA)0.15
Return on Invested Capital (ROIC)17.34%
Return on Capital Employed (ROCE)0.23
Revenue Per Employee7.27M
Profits Per Employee1.24M
Employee Count5,311
Asset Turnover0.90
Inventory Turnover2.53
Valuation Ratios
The current PE Ratio of JB Chemicals & Pharmaceuticals Ltd. is 36.0. JB Chemicals & Pharmaceuticals Ltd.’s PEG ratio is 1.96.
PE Ratio36.0
PS Ratio6.37
PB Ratio7.17
Price to Fair Value7.17
Price to FCF30.57
Price to Operating Cash Flow84.80
PEG Ratio1.96
Income Statement
In the last 12 months, JB Chemicals & Pharmaceuticals Ltd. had revenue of 38.62B and earned 6.60B in profits. Earnings per share was 42.45.
Revenue38.62B
Gross Profit25.22B
Operating Income8.55B
Pretax Income8.87B
Net Income6.60B
EBITDA10.69B
Earnings Per Share (EPS)42.45
Cash Flow
In the last 12 months, operating cash flow was 3.62B and capital expenditures -466.90M, giving a free cash flow of 3.16B billion.
Operating Cash Flow3.62B
Free Cash Flow3.16B
Free Cash Flow per Share19.66
Dividends & Yields
JB Chemicals & Pharmaceuticals Ltd. pays an annual dividend of ₹7, resulting in a dividend yield of 0.86%
Dividend Per Share₹7
Dividend Yield0.86%
Payout Ratio33.16%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.49
52-Week Price Change27.53%
50-Day Moving Average1.99K
200-Day Moving Average1.79K
Relative Strength Index (RSI)36.77
Average Volume (3m)2.67K
Important Dates
JB Chemicals & Pharmaceuticals Ltd. upcoming earnings date is May 21, 2026, TBA (Confirmed).
Last Earnings DateJan 16, 2026
Next Earnings DateMay 21, 2026
Ex-Dividend Date―
Financial Position
JB Chemicals & Pharmaceuticals Ltd. as a current ratio of 3.04, with Debt / Equity ratio of 1.07%
Current Ratio3.04
Quick Ratio2.20
Debt to Market Cap<0.01
Net Debt to EBITDA-0.09
Interest Coverage Ratio79.93
Taxes
In the past 12 months, JB Chemicals & Pharmaceuticals Ltd. has paid 2.28B in taxes.
Income Tax2.28B
Effective Tax Rate0.26
Enterprise Valuation
JB Chemicals & Pharmaceuticals Ltd. EV to EBITDA ratio is 22.92, with an EV/FCF ratio of 30.45.
EV to Sales6.34
EV to EBITDA22.92
EV to Free Cash Flow30.45
EV to Operating Cash Flow27.15
Balance Sheet
JB Chemicals & Pharmaceuticals Ltd. has ₹9.01B in cash and marketable securities with ₹409.10M in debt, giving a net cash position of ₹8.60B billion.
Cash & Marketable Securities₹9.01B
Total Debt₹409.10M
Net Cash₹8.60B
Net Cash Per Share₹53.59
Tangible Book Value Per Share₹129.72
Margins
Gross margin is 66.95%, with operating margin of 22.13%, and net profit margin of 17.08%.
Gross Margin66.95%
Operating Margin22.13%
Pretax Margin22.98%
Net Profit Margin17.08%
EBITDA Margin27.68%
EBIT Margin23.25%
Analyst Forecast
The average price target for JB Chemicals & Pharmaceuticals Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast10.25%
EPS Growth Forecast17.01%